Treace Medical Concepts, Inc.
TMCI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630627
In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Treace Medical Concepts, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +15 vs. Q3 2022
- Shares held
- 28.4M
- +2.26M (+8.7%) vs. Q3 2022
- Total value
- $617.6M
- +$41.8M (+7.3%) vs. Q3 2022
- New holders
- 24
- 41 more added
- Sold out
- 9
- 26 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TMCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 116 | $126.8M |
| Q1 2026 | 118 | $48.3M |
| Q4 2025 | 115 | $87.8M |
| Q3 2025 | 119 | $260.3M |
| Q2 2025 | 125 | $226.1M |
| Q1 2025 | 138 | $315.3M |
| Q4 2024 | 135 | $277.8M |
| Q3 2024 | 134 | $229.8M |
| Q2 2024 | 128 | $264.3M |
| Q1 2024 | 132 | $538.0M |
| Q4 2023 | 127 | $522.9M |
| Q3 2023 | 123 | $513.8M |
| Q2 2023 | 137 | $995.8M |
| Q1 2023 | 123 | $895.1M |
| Q4 2022 | 106 | $617.6M |
| Q3 2022 | 91 | $575.8M |
| Q2 2022 | 84 | $331.6M |
| Q1 2022 | 75 | $385.4M |
| Q4 2021 | 77 | $431.0M |
| Q3 2021 | 62 | $350.7M |
| Q2 2021 | 71 | $406.7M |
| Q1 2021 | 1 | $6.00K |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Treace Medical Concepts, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Emerald Advisers, LLC | 1,188,246 | $27.3M | 1.32% | +67,481+6.0% | Added |
| Next Century Growth Investors LLC | 1,595,387 | $36.7M | 4.40% | +20,018+1.3% | Added |
| Perceptive Advisors LLC | 1,946,403 | $44.7M | 1.29% | +344,424+21.5% | Added |
| BlackRock Inc. | 2,364,056 | $54.3M | 0.00% | +95,145+4.2% | Added |
| Alliancebernstein L.P. | 3,196,422 | $73.5M | 0.03% | −60,924−1.9% | Reduced |
| Vanguard Group Inc | 3,276,849 | $75.3M | 0.00% | +57,847+1.8% | Added |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −132,637−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −39,936−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −28,282−100.0% | Sold out |
| Cna Financial Corp | 0 | $0 | 0.00% | −26,994−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −23,707−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −20,791−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,373−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −1,340−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |